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Abstract
Genetic variation in the major histocompatibility complex (MHC) affects CD4:CD8 lineage commitment and MHC expression.
However, the contribution of specific genes in this gene-dense region has not yet been resolved. Nor has it been
established whether the same genes regulate MHC expression and T cell selection. Here, we assessed the impact of natural
genetic variation on MHC expression and CD4:CD8 lineage commitment using two genetic models in the rat. First, we
mapped Quantitative Trait Loci (QTLs) associated with variation in MHC class I and II protein expression and the CD4:CD8 T
cell ratio in outbred Heterogeneous Stock rats. We identified 10 QTLs across the genome and found that QTLs for the
individual traits colocalized within a region spanning the MHC. To identify the genes underlying these overlapping QTLs, we
generated a large panel of MHC-recombinant congenic strains, and refined the QTLs to two adjacent intervals of ,0.25 Mb
in the MHC-I and II regions, respectively. An interaction between these intervals affected MHC class I expression as well as
negative selection and lineage commitment of CD8 single-positive (SP) thymocytes. We mapped this effect to the
transporter associated with antigen processing 2 (Tap2) in the MHC-II region and the classical MHC class I gene(s) (RT1-A) in
the MHC-I region. This interaction was revealed by a recombination between RT1-A and Tap2, which occurred in 0.2% of the
rats. Variants of Tap2 have previously been shown to influence the antigenicity of MHC class I molecules by altering the
MHC class I ligandome. Our results show that a restricted peptide repertoire on MHC class I molecules leads to reduced
negative selection of CD8SP cells. To our knowledge, this is the first study showing how a recombination between natural
alleles of genes in the MHC influences lineage commitment of T cells.
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Introduction
Major histocompatibility complex (MHC) genes have been
identified in all vertebrate species [1]. The 3.6 Mb human
leukocyte antigen (HLA) was one of the first MHC to be
sequenced, and revealed a region with extraordinary complexity
[2]. The region contains ,260 genes that are clustered in sub-
regions denoted MHC-I, MHC-II and MHC-III [3]. Genes in the
MHC were early recognized for their extreme sequence diversity
and association with autoimmune and inflammatory conditions
(reviewed in [4]). However, these associations have been difficult
to delineate since nearly 40% of the MHC genes have immune-
related functions [2]. The interpretation of association data is
further complicated by the extensive linkage disequilibrium (LD)
across the region [5]. While the LD structure [6,7] and genetic
variation [3,8] of the HLA in humans is rather well investigated,
similar detailed analysis for the MHC in other species is needed.
The first complete sequence of the rat MHC (RT1) on
chromosome 20 was derived from the Brown Norway (BN) strain
(RT1n) and released in 2004 [9]. The BN genome sequence, which
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is also the rat reference sequence (RefSeq), was published shortly
thereafter [10]. Several inbred rat strains have since then been
resequenced, including the Spontaneously Hypertensive Rat
(SHR, RT1k) [11], and more recently, the DA (RT1av1), F344
(RT1lv1) [12] and a panel of additional strains [13]. The genetic
organization of the MHC is similar in rats and humans, with the
exception of a proximal classical MHC class Ia region (RT1-A)
[14] and a larger number of telomeric, non-classical, class Ib genes
(RT1-CEM) [15] in the rat. MHC class Ib molecules are
structurally similar to class Ia molecules but the corresponding
class Ib genes are less polymorphic, expressed at lower levels and
several are pseudogenes [16,17]. The number of functional class Ia
genes (RT1-A1, RT1-A2, RT1-A3) in the rat varies between one
and three in standard inbred strains [18,19]. These genes are
highly polymorphic and densely expressed on the surface of
virtually all nucleated cells where they engage in presentation of
intracellular antigens to cytotoxic CD8 T cells. The class Ia genes
are surrounded by highly conserved framework genes, which are
found in the MHC of all mammals, as well as several antigen
processing and transportation genes [9]. To this latter group of
genes belong the c-interferon-inducible proteasome subunit beta
type 8 (Psmb8) and Psmb9, and Tap1 and Tap2, which are all
located in the MHC-II region. An additional gene in this group,
Tap binding protein (Tapbp), is located centromeric to the class Ia
genes in the MHC-I region. These genes show limited allelic
variation in humans and mice [20,21]. In the rat, by contrast,
allelic variants of Tap2 fall into two groups, Tap2A and Tap2B,
which encode two functionally distinct allotypic forms of Tap2
[22,23]. Consequently, the two variants of TAP transporters
encoded by Tap1 and Tap2A or Tap2B are denoted TAP-A and
TAP-B, respectively [19]. Analyses of inbred rat strains have
revealed a significant degree of co-evolution between alleles in
Tap2 and the class Ia loci [19] and based on these studies RT1-A
molecules have been classified as either TAP-A or TAP-B linked
[19,24]. Livingstone and colleagues have shown that if linkage is
lost between RT1-Aa (the DA allele of class Ia) and the Tap2A
allele, as in the event of a recombination, the antigenicity of the
class Ia molecule is altered [25]. This phenomenon, known as class-
I modification (cim), has been explained by the peptide selectivity of
the different TAP isoforms [26,27] and more specifically by the
inability of the TAP-B transporter to translocate peptides with C-
terminal arginine residues, which are required for optimal loading
of RT1-Aa molecules [28]. This was followed by studies showing
that cim leads to abnormally slow assembly and reduced
extracellular class I expression of RT1-Aa molecules [22,29]. By
contrast, no such effects have been described for TAP-B-linked
RT1-A molecules when associated with the promiscuous TAP-A
transporter. Within the MHC-II region are four additional antigen
processing genes encoding the a and b subunits of RT1-DM and
RT1-DO. These non-classical class II molecules are responsible
for editing the peptide cargo of the classical class II molecules
before these are translocated to the cell surface to present peptides
to helper CD4 T cells.
Expression of MHC class I and II molecules on antigen
presenting cells is required for T cell selection in the thymus
[30,31] and for the survival of mature T cell subsets in the
periphery [32,33]. The commitment of thymocytes to CD4 or
CD8 lineage is determined mainly by the MHC peptide repertoire
and the antigen specificity of the T cell receptor (TCR). The
variation in CD4 and CD8 T cell numbers is associated with genes
in the MHC in humans [34], mice [35] and rats [36]. However, it
is not known whether the levels of MHC expression and/or
polymorphisms in other genes than the classical MHC class I and
II genes, such as the aforementioned antigen processing genes,
contribute to this variation.
Here, we assessed the impact of the genetic variation on class I
and II expression and T cell selection using two genetic rat models:
the NIH-Heterogenous Stock (HS) and a panel of MHC-
recombinant congenic strains. The NIH-HS is descended from
eight inbred strains through 60 generations of outbreeding [37].
The greater genetic diversity in the HS compared to a
conventional F2 cross allows mapping of more QTLs [38], which
was exploited here to identify genomic regions (QTLs) that
contribute both to MHC expression and the variation in
CD4:CD8 T cell ratio. Recombinant congenic strains (RCS) are
powerful tools to resolve complex QTLs in regions with extensive
LD. In RCS, haplotype blocks that are the result of rare
recombinations can be preserved, which allows investigation of
multiple phenotypes using genetically identical individuals [39,40].
We describe a new panel of rat RCS, in which MHC segments
from four inbred strains have been inserted on the background of
the DA strain.
In the rat HS we identified a region spanning 4.1–9.7 Mb on
chromosome 20 that contributed to both the variation in MHC
expression and CD4:CD8 T cell ratio. Mapping using RCS
identified two intervals, each ,0.25 Mb wide, in the MHC-I and
II region that contributed to the phenotypic variation, suggesting
that the HS QTL might result from two linked QTLs. First, we
showed that the variation in class I expression correlated with
alleles of Tap2, which is in line with previously reported data [25].
Second, we identified a novel type of class-I modification that we
termed inverse cim, which reduced the expression of TAP-B linked
RT1-A molecules if associated with TAP-A. Finally, we showed
that polymorphisms in Tap2 significantly contribute to CD8
lineage commitment, likely by altering the class-I peptide
repertoire on antigen presenting cells in the thymus.
Results
QTLs for CD4:CD8 T cell ratio and MHC expression
overlap within the MHC region
T cell selection and the maintenance of the peripheral T cell
pool rely on the interaction between peptide-MHC complexes and
T cell receptors. The variation in the relative proportion of
Author Summary
Peptides from degraded cytoplasmic proteins are trans-
ported via TAP into the endoplasmic reticulum for loading
onto MHC class I molecules. TAP is encoded by Tap1 and
Tap2, which in rodents are located close to the MHC class I
genes. In the rat, genetic variation in Tap2 gives rise to two
different transporters: a promiscuous A variant (TAP-A) and
a more restrictive B variant (TAP-B). It has been proposed
that the class I molecule in the DA rat (RT1-Aa) has co-
evolved with TAP-A and it has been shown that RT1-Aa
antigenicity is changed when co-expressed with TAP-B. To
study the contribution of different allelic combinations of
RT1-A and Tap2 to the variation in MHC expression and T
cell selection, we generated DA rats with either congenic
or background alleles in the RT1-A and Tap2 loci. We found
increased numbers of mature CD8SP cells in the thymus of
rats which co-expressed RT1-Aa and TAP-B. This increase of
CD8 cells could be explained by reduced negative
selection, but did not correlate with RT1-Aa expression
levels on thymic antigen presenting cells. Thus, our results
identify a crucial role of the TAP and the quality of the
MHC class I repertoire in regulating T cell selection.
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peripheral CD4 and CD8 T cells has been associated with the
MHC [34–36]. In order to investigate if there is a shared genetic
regulation of MHC expression and T cell numbers, we first
identified genome-wide QTLs that controlled the CD4:CD8 T cell
ratio and MHC class I and II expression in the rat NIH-HS [41].
We measured the number of circulating CD4 and CD8 T cells and
extracellular MHC class I and II expression by flow cytometry in
more than 2000 HS rats, of which 1407 were genotyped at 265,551
SNPs. Each HS rat chromosome was reconstructed as a mosaic of
the founder genomes, and QTLs were mapped using two methods
that take the different levels of relatedness existing in the rat HS into
account (see Materials and Methods). We report QTLs detected at a
false discovery rate of 10%, which corresponds to a negative logP
threshold of 4.2 for the three measures studied here.
The mean ratio of circulating CD4 vs. CD8 T cells in the HS
rats was 2.76 (range 1.0–13.8), which is concordant with data
previously obtained in the inbred founder strains [42]. Variation in
this phenotype was explained mainly by QTLs on chromosomes 9
and 20 (Fig. 1). The intervals most significantly associated with this
phenotype were located at 4.20 Mb at the proximal end of
chromosome 9 (2logP = 22.1), and at 4.78 Mb in the MHC
region on chromosome 20 (2logP = 36.5). The effect sizes of these
QTLs were estimated to be 14.4% and 14.6% respectively (upper
bound; Fig. 1C). These QTLs also contributed to variation in
absolute numbers of CD4 and CD8 T cells (data not shown,
genome scans are accessible on the WTCHG website: http://mus.
well.ox.ac.uk/gscandb/rat).
The surface expression of MHC class I was determined on
granulocytes using a widely reactive MHC class I antibody to Ia and
Ib molecules. QTLs for this phenotype were found on chromosome
2 (2logP = 4.27), 10 (2logP = 8.77) and 20 (2logP = 29.5), of which
only the latter coincided with a QTL for CD4:CD8 T cell ratio.
Three regions were associated with MHC class II (RT1-B)
expression on B cells. These were located on chromosome 2 (2
logP = 4.75), 17 (2logP = 13.8) and 20 (2logP = 5.66). The most
significantly associated marker on chromosome 20 was located at
4.87 Mb in the MHC region. Because the median 90% confidence
interval for the position of the QTLs mapped in the rat HS is
4.5 Mb, this QTL overlapped with the QTL identified for
CD4:CD8 T cell ratio on this chromosome.
In summary, using a genome-wide approach, we showed that
CD4:CD8 T cell ratio and MHC expression might be regulated by
a common QTL or a set of closely linked QTLs in the rat MHC
region. However, the majority of identified QTLs for these traits
did not co-localize, suggesting that variation in MHC expression is
not a strong determinant of the CD4:CD8 T cell ratio.
Generation of MHC recombinant congenic strains
We next aimed to isolate the intervals associated with the
phenotypic variation in the MHC, since the mapping in the HS
rats did not distinguish whether a single gene with pleiotropic
action or different MHC genes controlled MHC class I and II
expression and the CD4:CD8 T cell ratio.
We therefore established MHC congenic strains with RT1f,
RT1i, RT1u and RT1h haplotypes on the homozygous DA
(RT1av1) background that showed phenotypic variation in
CD4:CD8 T cell ratio and class I and II expression (Table 1).
We produced a panel of more than 40 RCS with segments in the
MHC-I, -II and -III regions (selected strains are shown in Figure 2).
We identified 70 recombinations within a 2 Mb genomic region
(3.4–5.4 Mb) (Fig. 3) and mapped the recombination breakpoints
using 67 SNP and short-tandem repeat (STR) markers (Table S1
and Table S2) to intervals of 2–270 kb. Three recombination
hotspots were identified near DMb, Btnl2 and Lta (Fig. 3), which
Figure 1. Genetic mapping in heterogeneous stock (HS) rats. (A) Genome scans of the CD4:CD8 ratio (green), and the surface expression of
MHC class I (MHC-I, red) and MHC class II (MHC-II, blue). The vertical axis shows the negative log P value for the 20 autosomes. Note that the left and
right axis show 2log P values for different phenotypes. Q1–Q10 indicate significant QTLs. (B) Close-up for Q8–Q10 on chromosome 20 showing the
approximate location of the MHC region. (C) Position (in megabases, Mb) of peak marker (Pos.), confidence intervals (CI) in Mb, and effect sizes (%) of
the peak markers in the QTLs shown in (A). The RMIP value is a measure of the probability that the loci are correctly identified (max= 1.0).
doi:10.1371/journal.pgen.1004151.g001
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are also located close to recombination hotspots in the human
HLA [6,8,43,44]. We did not identify any recombination events in
the MHC-II region between DMb and Btnl2, despite analyzing
,29,000 meiotic events. Extensive LD was also observed between
Kifc1 and Coll11A2 in the MHC-I region where only a single
recombination near the Kifc1 gene was identified among the
,16,000 analyzed meiotic events. Thus, recombinations in the
RT1 between the MHC-I and -II regions occur relatively
frequently (0.2%), while the recombination activity within each
of these regions is extremely low. The extensive LD between DMb
and Btnl2 as well as between Kifc1 and Coll11A2 therefore gave rise
to two haplotypes that could be isolated as congenic segments in
the RCS panel.
Two linked QTLs in RT1 regulate CD4:CD8 T cell ratio and
MHC expression
The RCS panel allowed the identification of two intervals in
RT1 associated with the variation in CD4:CD8 T cell ratio and
MHC expression (Table 1). The first interval, which we named T
cell selection QTL 1 (Tcs1), was identified within the MHC-I region
(Fig. 2) using DA.1IR85, DA.1HR83 and DA.1UR83 (we refer to
these strains as Tcs1-congenic strains). This QTL, which regulated
class I cell surface expression and the CD4:CD8 T cell ratio, was
determined to 0.282 Mb (min-max: 0.242–0.323 Mb) based on
the average size of the intervals of unknown genotype (congenic
borders) in phenotype-negative DA.1IR86 and DA.1IR84 rats
(Fig. 2). The second QTL, denoted T cell selection QTL 2 (Tcs2), was
mapped to the MHC-II region using the Tcs2-congenic strains
DA.1UR10, DA.1HR10 and DA.1FR9 (Fig. 2). Since DA.1FR61
(Fig. 2) was not yet available at the time of the investigation, we
used DA.1FR10 and DA.1FR8 (both phenotype-negative) to
exclude genes in the MHC-III and RT1-CEM region of DA.1FR9
(Fig. 2). Recombination events in DA.1UR10 within Btnl2
(between intron 5 and 6) and in DA.1HR10 within RT1-DMb
(between intron 2 and 5) constituted the telomeric and centromeric
boundaries of Tcs2, which was determined to 0.206 Mb (min-max:
0.197–0.214 Mb) (Fig. 2). This QTL regulated the cell surface
expression of class I and II as well as the CD4:CD8 T cell ratio.
Tcs1 and Tcs2 together explained all variation in the CD4:CD8
T cell ratio and extracellular MHC expression associated with
RT1 in the RCS. This suggests that these two linked haplotypes
are also responsible for the phenotypic variation mapped to
chromosome 20 in the HS. While Tcs2 alone controlled MHC
class II expression, both QTLs, Tcs1 and Tcs2, controlled cell
surface expression of MHC class I and the variation in CD4:CD8
T cell ratio. The effect of the MHC-II region on MHC class I
expression has previously been ascribed to allelic variants of Tap2
[25]. Since the other genes in Tcs2 are in strong LD with Tap2, we
next compared the genetic variation of these genes in order to
identify their individual contribution.
Genes encoding proteins in the MHC class I and II
pathways show variable degrees of sequence
conservation
Two QTLs, Tcs1 in the MHC-I region and Tcs2 in the MHC-II
region, were associated with the variation in CD4:CD8 T cell ratio
and MHC expression. In order to identify the causative genes in
Tcs1 and Tcs2 associated with these traits, we determined the
genetic variation of genes encoding proteins in the MHC class I
and II pathways (all genes in Tcs2, Tapbp in Tcs1) by direct
sequencing. These analyses of congenic (RT1f,h,i,u), wild-type
(RT1a) and RefSeq (RT1n) haplotypes revealed 367 exonic SNPs
Table 1. CD4:CD8 T cell ratio and extracellular MHC class I and II expression in spleens of congenic and recombinant strains.
RT1a MHC-IIb,d
Strain n A B D CEM CD4:CD8 MHC-Ib,c RT1-B RT1-D
WT DA 10 a a a a 4.160.3 100612 10065.4 10067.4
PS DA.1F 10 f f f f 2.960.2e 8367.0f 6764.9e 9866.6
PS DA.1H 6 h h h h 7.560.4f 9264.3 7464.8e 8863.9f
PS DA.1I 10 i i i a 6.960.4e 6765.4e 9767.2 9765.6
PS DA.1U 7 u u u u 2.460.3e 9266.0 7966.5e 9665.4
RCS DA.1FR9 7 a f f a 2.960.1e 9668.0 5864.3e 101616
RCS DA.1HR10 6 a h h a 3.860.3 7567.0f 7868.5f 8565.3f
RCS DA.1IR7 9 a i i a 4.460.4 10364.7 102613 10069.4
RCS DA.1UR10 7 a u u a 3.060.1e 7963.8f 7062.3e 10768.0
RCS DA.1HR83 5 h a a a 7.160.6f 8566.0g 101611 9867.1
RCS DA.1IR85 5 i a a a 8.260.7f 6861.1f 10460.9 10163.6
RCS DA.1UR83 5 u a a a 3.260.2f 8862.4g 10364.5 10064.1
aRT1 haplotype designations are based on genotyping data (see Methods);
bStrains were compared in separate experiments to DA littermate controls. The mean fluorescent intensity was then normalized to the expression of DA, which was
given an arbitrary value of 100.
cMHC-I (class Ia and Ib; OX18) extracellular expression on WBCs.
dMHC class II expression on B cells.
Significant differences compared to DA:
eP,0.001;
fP,0.01;
gP,0.05.
WT, wildtype; PS, parental strain; RCS, recombinant congenic strain. Shown are mean values 6SD.
doi:10.1371/journal.pgen.1004151.t001
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Figure 2. Physical map of the rat MHC region. The map was constructed according to the NCBI build 3.4 genome assembly. Genes (left) are
depicted according to scale (positions in Mb), except for positions indicated with crotchets. The gross organization of MHC-Ia, II, III and Ib -regions are
adopted from Hurt et al. [9]. Recombinant congenic strains are shown as gray vertical bars with dashed lines representing congenic borders (intervals
of unknown genotype). Markers, short tandem repeats (STRs) and single nucleotide polymorphisms (SNPs), are shown in italic numbers. Numbers
with asterisks at the top and bottom of the figure represent the position of the closest negative (DA) marker. Genes in Tcs1 are red and in Tcs2 blue
(see box for definitions). Inset shows the organization of the human (HLA) and rat (RT1) MHC regions. Non-recombinant congenic strains, which have
fragments spanning the entire MHC region, are not shown. xMHC-II, extended MHC class II region; xMHC-I, extended MHC class I region.
doi:10.1371/journal.pgen.1004151.g002
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(synonymous and nonsynonymous), 15 indels (insertions/deletions)
and 168 amino acid (aa) substitutions in the corresponding
proteins (Table 2).
The genes associated with the MHC class I pathway (Tap1,
Tap2, Psmb8, Psmb9 and Tapbp) showed variable degrees of
sequence conservation (Fig. 4). The most conserved gene was
Tapbp, with only a single nonsynonymous SNP (nsSNP) coding for
R165H in the corresponding protein (alternative allele in the
RT1u haplotype, Table 2). Psmb9 contained one nsSNP in a region
coding for the propeptide while three nsSNPs were found in Psmb8
Table 2. Sequence variants and allele distribution of genes in six rat MHC haplotypes.
Genea Sizeb SNPc deld Allele 1e Allele 2 Allele 3 Allele 4 Allele 5 Allele 6 Subsf Isofg
Btnl2h 1542 4 0 a n u 3 2
RT1-Da 768 7 0 a f i h n u 1 2
RT1-Db2 861 2 3 a f i n u 0 2
RT1-Db1 795 76 9 a f i h n u 35 3
RT1-Ba 768 66 3 a i h n f u 40 4
RT1-Bb 792 72 0 a i h n f u 38 4
RT1-DObi 819 19 0 a i h n f u 7 4
Tap2 2112 61 0 a i h n f u 28 4
Psmb8 831 14 0 a i h n f u 3 3
Tap1 2178 26 0 a f i h n u 10 6
Psmb9 661 5 0 n i f u a h 1 2
RT1-DMb 785 8 0 n i a f h u 1 2
RT1-DMa 783 5 0 a f h n i u 0 1
Tapbp 1563 2 0 a f n h i u 1 2
aAll genes except RT1-DMa and Tapbp are encoded within the Tcs2 locus.
bSize of the coding sequences (cds) in bp.
cTotal number of synonymous and nonsynonymous SNPs in the cds.
dTotal number of insertions/deletions on gene level.
eAllele distribution between MHC haplotypes; DA (RT1a), DA.1F (RT1f), DA.1I (RT1i), DA.1H (RT1h), DA.1U (RT1u). Sequence information for RT1n was obtained from NCBI
GenBank.
fTotal number of amino acid substitutions.
gNumber of alternative isoforms at the protein level.
hBtnl2 was analyzed in only two strains.
ISequence information for RT1-DOb refers to the full-length transcript of this gene (see Fig. S1 for alternative transcript).
doi:10.1371/journal.pgen.1004151.t002
Figure 3. Recombination hotspots and haplotype blocks in the rat MHC. Recombination activity was assessed over 2 Mb (3.4–5.4 Mb). Blue
lines represent cold regions (haplotype blocks) with low recombination activity. Regions with recombinations are depicted as red bars. The width of
the bars, and the table inset (right), represent recombination intervals. Numbers above bars in bold face represent the observed numbers of
recombinations within the interval with the number of analyzed meiotic events shown below. The height of the bars indicate individuals with
recombinations (in %). Blue triangles represent recombination hotspots in humans and are adopted from Cullen et al. [6].
doi:10.1371/journal.pgen.1004151.g003
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(Fig. 4), although not in positions predicted to influence
immunoproteasome assembly or the chymotrypsin-like activity of
the corresponding protein [45]. By contrast, both Tap1 and Tap2
showed extreme sequence diversity. We identified six allelic
variants of Tap1, including unique alleles for the RT1i and RT1h
haplotypes, and four allelic variants of Tap2 (Fig. 4). Three of the
Tap2 alleles have not been sequenced previously: Tap2h, Tap2f and
Tap2i, of which the latter was found to be identical to Tap2a
(Table 2). Our sequence analysis confirms previous categorization
of these alleles using restriction endonucleases [23] as Tap2A (RT1f
and RT1i) and Tap2B (RT1h), respectively. This categorization of
Tap2 alleles is based on nsSNPs coding for the amino acids 217,
218, 262, 265, 266 (asterisked in Fig. 4) in the Tap2 polypeptide,
which determine the peptide specificity of the TAP complex
[46,47].
Variable sequence diversity was also observed for the genes in
the MHC class II pathway (DOb, DMa and DMb). The Tcs1 and
Tcs2 intervals excluded the DMa gene as well as the only nsSNP in
Figure 4. Coding variants in T cell selection QTL 2 (Tcs2). Nonsynonymous- and structural variants in Tcs2 were determined by Sanger
sequencing of DA.1F (f), DA (a), DA.1I (i), DA.1U (u) and DA.1H (h) (see also Table 2). Amino acid substitutions are indicated in standard single letter
codes and insertions/deletions as DEL. Gene annotations are from UniProt; protein domains depicted in DOb are derived from the human homolog.
Letters in boxes depict residues with background allele (DA) with numbers above indicating amino acid positions in the translated cds. On top is a
schematic illustration of the genes in the region according to the 3.4 genome assembly (genes outside the QTL are shown in gray). Annotations used:
TM, transmembrane domain; CD, cytoplasmic domain; CP, connecting peptide; b1, beta 1 domain; b2, beta 2 domain; a1, alpha 1 domain; a2, alpha 2
domain. *Residues associated with class-I modification (cim).
doi:10.1371/journal.pgen.1004151.g004
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DMb (corresponding to aa position 12) (Fig. 4). The DOb gene was
found to be more polymorphic in the rat than previously shown for
mice and humans [48], with a total of seven aa substitutions in the
corresponding protein (Fig. 4). Two transcripts of DOb, which
differed in length by 77 bp due to a deletion in exon 3, were
identified in both congenic strains and DA (Fig. S1 and Fig. S2).
The rat expresses two classical MHC class II loci, RT1-B and
RT1-D. Three MHC class II genes, RT1-Ba, -Bb and -Db1 were
highly polymorphic across the six haplotypes studied here, whereas
RT1-Da was largely conserved with only a single nsSNP (Fig. 4).
The existence of a second putative b-locus of RT1-D has been
suggested [9]. Our data show that this gene, RT1-Db2, is expressed
and that it is monomorphic at the protein level in DA and MHC-
congenic strains (data not shown). We could further show by mass
spectrometry that RT1-Db2 forms an ab-heterodimer with RT1-
Da and confirm at the protein level that RT1-Db2 has a 22
residue extended cytoplasmic tail, which does not exist in RT1-
Db1 (Fig. S3).
Taken together, among the genes in the MHC class I pathway,
only Tap2 had an allele distribution that correlated with the
variation in MHC class I expression (Fig. 4, Table 1). The effect of
different Tap2 alleles on MHC class I expression has previously
been established [25,29], and we therefore suggest Tap2 as the
only causative gene in Tcs2 for this phenotype. In addition, these
data exclude functional polymorphisms in Tapbp as responsible for
the Tcs1 QTL in MHC-I. Hence, the variations in MHC class I
expression and the CD4:CD8 T cell ratio associated with this
QTL are likely to be due to polymorphisms in the RT1-A genes
and/or the number of functional protein-coding RT1-A genes per
MHC-I haplotype.
Expression of class I proteins in Tcs1-congenic rats
The number of RT1-A genes in standard inbred rat strains
varies from one in the RT1lv1 and RT1a haplotypes to three in the
RT1n,o,d,m haplotypes [14,18]. It has therefore been suggested that
the number of RT1-A genes influences the selection of CD8 T cells
[36]. The expression of RT1-A at the protein level has previously
been characterized using allotypic antibodies [18,49–52], while the
phenotypes we mapped in the HS and RCS were determined
using the widely reactive MHC class I antibody OX18, which does
not discriminate between different isoforms of RT1-A. In order to
assess the number of functional protein-coding RT1-A genes in
DA.1IR85 and to confirm the expression of RT1-Aa, A1h and
A2h, and Au as the only class Ia molecules in DA and the Tcs1-
congenic strains, we analyzed trypsin-digested cell lysates of IFN-c
stimulated splenocytes from these strains by mass spectrometry.
The comparison of DA and the Tcs1-congenic strains also allowed
the identification and discrimination of classical Ia and non-
classical Ib proteins, since these strains encode different RT1-A
genes but the same RT1-CEM genes.
We identified between 5 and 17 peptides (Mascot score .20)
per strain that matched rat class Ia and Ib entries in public
databases. In DA, 11 of 17 identified peptides matched the RT1-
Aa molecule described by Rada et al. [53], while four peptides
matched the UniProt entry HA11_RAT (Table 3, Fig. S4).
HA11_RAT is the UniProt entry of the class Ib gene RT1-EC2
(RGD), which was isolated from a DA cDNA library as clone 3.6
[53] and predicted to be the rat homologue of mouse H2-Q10
[54]. All four peptides identified in DA.1UR83 were derived from
a single class Ia molecule (Table 3, Fig. S5), which is consistent
with previous observations that the RT1a and the RT1u
haplotypes express only one class Ia gene each (RT1-Aa and
RT1-Au, respectively) [53,55]. In DA.1IR85 and DA.1HR83, 12
and 13 peptides, respectively, allowed the discrimination of two
different RT1-A isoforms (A1 and A2) in each strain (Table 3, Fig.
S6 and S7). In DA.1HR83 we also identified one peptide unique
to clone 3.6 and two peptides that were shared between all
identified class I molecules (Fig. S7). None of the analyzed samples
contained peptides unique to an A3 isoform, which has been
cloned in rats with haplotype RT1o/d/m [18] and RT1n [14].
Taken together, our results show that DA.1IR85 and
DA.1HR83 express two functional protein-coding RT1-A genes,
A1n/A2n and A1h/A2h, respectively. We did not identify an A3
isoform in DA.1IR85, which is unexpected since the RT1-A
region in DA.1IR85 is supposedly derived from the BN strain
(RT1n) [56]. In DA and DA.1UR83 we only identified one RT1-A
molecule per haplotype, which is in line with previous studies
[53,55].
A novel type of class-I modification influences class I
expression
Having established the number of protein-coding RT1-A genes
in DA.1IR85 and confirmed the protein expression of RT1-Aa,
A1h and A2h, and Au, we continued assessing the impact of TAP-A
and TAP-B on the expression levels of MHC class I molecules in
Tcs1 and Tcs2-congenic strains.
Mapping in the RCS identified two adjacent QTLs for class I
expression, Tcs1 and Tcs2. Tcs2 aligned with the principles of the
classical cim phenomenon [25]. Tcs1, by contrast, was unexpected
since the RT1-A genes in the Tcs1-congenic strains are associated
with Tap2A, which encodes the promiscuous TAP-A transporter.
We therefore hypothesized that this QTL was due to a novel type
of class I modification in which the cell surface expression of TAP-
B-linked RT1-A molecules (RT1-An, RT1-Au and RT1-Ah) was
reduced by the presence of TAP-A. We termed this TAP-A-
mediated class-I modification inverse cim. To test this hypothesis, we
analyzed the intra- and extracellular expression of class I in the
Tcs1-congenic strains (Tap2A), DA (Tap2A) and in two non-
recombinant parental strains, DA.1H and DA.1U (both Tap2B).
The expression of class I was determined using the OX18
antibody that binds both A1 and A2 isoforms [57]. However, since
OX18 in addition recognizes class Ib molecules [58], which may
differ in numbers between the non-recombinant strains and DA,
we also used the class Ia specific antibody F16-4-4 [59]. This
antibody, on the other hand, reacts with a polymorphic
determinant (Fig. S8 and [52]) and was therefore only used to
Table 3. MHC class I proteins expressed in splenocytes from
DA and Tcs1-congenic strains.
F pocketa
Strain UniProt Entry Gene 77 97 116
DA HA12_RAT RT1-Aa D E D
DA HA11_RAT Clone 3.6 S R H
DA.1UR83 Q31256_RAT RT1-Au N V D
DA.1HR83 Q9QYQ2_RAT RT1-A2h S L F
DA.1HR83 Q9QYQ3_RAT RT1-A1h D L Y
DA.1HR83 HA11_RAT Clone 3.6 S R H
DA.1IR85 Q6MGB9_RAT RT1-A1n N R Y
DA.1IR85 Q6MGB8_RAT RT1-A2n D R D
aAmino acids in the F pocket, which discriminate TAP-A- from TAP-B-linked RT1-
A molecules [24].
doi:10.1371/journal.pgen.1004151.t003
Polymorphisms in Tap2 Influence T Cell Selection
PLOS Genetics | www.plosgenetics.org 8 February 2014 | Volume 10 | Issue 2 | e1004151
compare the class I expression between strains with the same RT1-
A haplotypes.
We first analyzed the extracellular levels of class I on spleen cells
expressing CD68, a marker of macrophages and dendritic cells in
the rat [60]. Consistent with the leukocyte data shown in Table 1,
CD68+ cells in DA.1HR83 and DA.1HR10 showed reduced
surface levels of class I compared to DA and DA.1H when stained
with OX18 (Fig. 5A) as well as with F16-4-4 (Fig. 5B). The lower
levels of class Ia in DA.1HR83 (RT1-Ah, TAP-A) compared to
DA.1H (RT1-Ah, TAP-B) suggest that RT1-Ah requires TAP-B
for optimal export to the cell surface, which would be consistent
with the inverse cim phenomenon.
The association of RT1-Aa to TAP-B has been shown to cause a
relative retention of class I molecules in the ER [25,29], implying
that the level of class I should be higher intracellularly in
DA.1HR10, and possibly also in DA.1HR83. However, we found
that the intracellular levels of class I in these strains were also
reduced compared to DA and DA.1H (Fig. 5C). These observations
were also confirmed using F16-4-4 in DA.1HR10 (Fig. 5C),
suggesting that both classical and inverse cim reduce the class I
expression on the cell surface as well as inside the cell. DA.1IR85
showed extremely low extracellular levels of class I staining on all
analyzed subsets of leukocytes as well as intracellularly in CD68+
cells (P,0.01; Fig. 5D, E). The intracellular levels of class I in
Figure 5. Regulation of class I expression by classical and inverse cim. (A) CD68+ cells were stained on the cell surface with OX18 (anti-class
Ia and Ib). Histograms show representative samples from DA, DA.1H and DA.1H derived strains with different alleles of RT1-A and Tap2 as stated on
top. Data from all individuals are shown in scatterplot (far right); * significant compared to DA.1H (1H); ** significant compared to DA. (B) CD68+ cells
stained with a class Ia specific antibody (F16-4-4). (C) T cells from animals shown in (A) stained intracellularly with OX18 (scatterplot) and F16-4-4
(histogram). (D–E) Subsets of leukocytes from DA and DA.1IR85 spleen stained extracellularly (D) and intracellularly (E) with OX18. Data are
representative of 6 individuals per group. (F) Surface expression of MHC class I (OX18) on CD68+ cells from DA and DA.1U congenic strains. (G) CD68+
cells (same as in F) stained with F16-4-4. Vertical lines in scatterplots show mean values. Representative results of at least two independent
experiments are shown.
doi:10.1371/journal.pgen.1004151.g005
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lymphocytes (T and B cells), by contrast, did not differ between DA
and DA.1IR85 (Fig. 5E), suggesting that at least one of the two
RT1-A molecules in DA.1IR85 is not efficiently transported to the
cell surface. It is difficult to fully evaluate the TAP restriction of
RT1-An in DA.1IR85 since the parental strain, DA.1I, is itself a
recombinant strain that expresses the Tap2A allele (Fig. 4).
However, the class Ia genes in DA.1IR85, RT1-A1n and RT1-A2n,
are naturally associated with Tap2B in BN, which does not show
reduced class I expression compared to ACI (RT1-Aa) [42]. This
suggests that TAP-A is not an optimal transporter of peptides for
RT1-A1n and/or RT1-A2n and that these molecules in DA.1IR85,
as well as in DA.1I, are affected by the inverse cim.
As expected, the class I expression in DA.1IR7 and DA.1FR9
(RT1-Aa, TAP-A), did not differ from DA (Table 1). Moreover, the
Tap2B allele in DA.1UR10 has previously been shown to encode an
inefficient transporter of peptides for RT1-Aa [61], which explains
the low surface expression of class I in this strain (Fig. 5F,G).
Leukocytes from the parental congenic strain DA.1U showed a
trend towards lower levels of class I on the cell surface compared to
DA (Table 1). This reduction in class I expression was statistically
significant on CD68+ cells in DA.1U as well as in DA.1UR83
(Fig. 5F). Hence, the reduced expression of class I in DA.1UR83,
which did not differ significantly from DA.1U (Fig. 5F,G), cannot be
ascribed to polymorphisms in the Tap2 gene and suggest that the
expression of RT1-Au is regulated at the transcriptional level.
Our data support a novel type of cim in which RT1-Ah and
probably also RT1-An require TAP-B for optimal expression at
the cell surface. However, we also found evidence for a cim-
independent regulation of extracellular class I levels for RT1-Au,
suggesting that regulation also takes place at the gene level.
Weak correlation between transcription and extracellular
expression of class I
The variation in MHC class I protein expression between
DA.1H and DA.1HR83 revealed that RT1-A1h and/or A2h were
reduced in the context of TAP-A. However, whether the
expression of MHC class I proteins in addition was influenced
by a variation in RT1-A gene expression in the Tcs1 congenic
strain was still unclear.
We therefore determined the expression levels in the spleen of
the six protein-coding RT1-A genes shown in Table 3. We
designed allele-specific primers based on published RT1-A
sequences to avoid off-target amplification of RT1-CEM genes
(Fig. 6A). Each target was amplified with 2–4 different primer sets
and the levels of product were averaged on the gene level and
compared to the expression of beta-2-microglobulin (B2M, Fig. 6B)
and to three reference genes (Fig. 6C). We observed the highest
transcript levels for RT1-A1n in DA.1IR85, which was ,5-fold
higher than RT1-A2n in this strain and ,3-fold higher than RT1-
Aa in DA. Hence, the high levels of intracellular MHC class I
proteins in DA.1IR85 T and B cells (Fig. 5E) correlated with a
high expression of RT1-A1n on the gene level. By contrast, such
correlation could not be found for RT1-A2h in DA.1HR83 and
RT1-Au in DA.1UR83, which had comparable expression levels to
RT1-Aa in DA despite their significant reduction in protein
expression (Fig. 5).
We also compared the expression of class Ia and Ib genes in DA
and found ,6-fold higher levels of RT1-Aa compared to clone 3.6
(Fig. 6D), which was the only class Ib gene that was identified at
the protein level (Table 3). Finally, we assessed the impact of Tcs1
on genome-wide transcription by exon-microarray. This showed
that all genes that were differentially expressed between DA and
DA.1IR83 (which has a slightly larger congenic fragment
compared to DA.1IR85) were located within the Tcs1 region
(Fig. S9). Hence, the phenotypic variation associated with Tcs1 is
unlikely to be due to trans-acting factors outside of the QTL.
Taken together, the extracellular expression of class I proteins
correlated poorly with the expression at the gene level. These data
therefore support the conclusion that class I expression on the cell
surface is largely regulated by polymorphisms affecting the peptide
binding pocket of the RT1-A molecules and the TAP transporter.
Regulation of MHC expression by dendritic cells is similar
in the thymus and spleen
The genetic variation in Tap2 influenced the extracellular
expression of class I molecules in the spleen. Next, we determined
the expression of MHC on thymic DCs, which control the egress
of T cells by eliminating self-reactive cells during negative selection
[62].
Comparing the class I expression at the protein level between
thymic DCs (Fig. 7A) and CD68+ cells in the spleen (Fig. 5)
showed that the variation between the strains was similar in both
Figure 6. Transcriptional regulation of MHC class I genes. (A)
Allele-specific primers (Prim.) used for quantitative RT-PCR showed
minimal amplification of other RT1-A alleles and were therefore
considered class Ia-specific (i.e. not cross-reacting to class Ib genes);
PCR products (Prod.) are shown for DA (a), DA.1UR83 (u), DA.1HR83 (h)
and DA.1IR85 (i). (B) Expression in spleen of RT1-A genes in DA and
Tcs1-congenic strains relative to the expression of beta-2-microglobu-
line (B2M). (C) Variation (fold-change) in RT1-A gene expression
between different congenic strains. Data show the mean expression
of 2–4 different primer sets per target gene after normalization to 3
reference genes (Table S3). Significant differences compared to RT1-Aa.
(D) Expression of RT1-Aa (class Ia) and clone 3.6 (class Ib) in spleen from
DA rats. The amplification of a product in DA.1HR83 but not in DA.1H
(1H) indicates that the primers for clone 3.6 are not cross-reacting to the
RT1-Aa gene in DA (adjacent figure).
doi:10.1371/journal.pgen.1004151.g006
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organs. This suggests that cim affects a broad repertoire of cells in
different tissues. Likewise, the variation in class II expression on
DCs in Tcs2-congenic strains was similar in the spleen (Fig. 7B)
and in the thymus (Fig. 7C), as well as between DCs and B cells in
the spleen (Table 1). Thus, we established that the genetic
variation in Tap2 also affects the extracellular class I expression on
antigen presenting cells in the thymus. We next aimed to
determine if Tap2 had a pleiotropic effect and was also responsible
for the variation in CD4:CD8 lineage commitment.
Classical cim affects lineage commitment and negative
selection of CD8 T cells
Classical and inverse cim influenced class I expression on
thymic DCs. We hypothesized that the changes associated with
cim in class I expression and/or in the quality of the peptide
repertoire would affect thymic selection and thereby contribute to
the variation in peripheral CD4 and CD8 T cell numbers.
The different maturation stages of thymocytes are defined by
the expression of various surface markers, which differ between
rats, mice and humans [63,64]. In the rat, double negative (DN)
cells are defined according to the expression of CD45RC and CD2
[65] (see also Figure S10). We first determined the progression
from the DN to the double positive (DP) stage in 6.5 week-old
Tcs1- and Tcs2-congenic rats. We found no variation in the total
number of DN cells (Fig. 8A, shown for Tcs2-congenic strains),
while the frequency of early thymic precursors (CD45RC+, CD2lo)
was reduced in DA.1FR9 compared to all other strains (Fig. 8B,
shown for DA vs. DA.1FR9). Moreover, all strains showed similar
frequencies of immature CD8a single positive (ISP) cells (data not
shown), whereas DA.1UR83 showed a greater proportion of cells
at late DN stage (corresponding to DN4 in the mouse), in which all
cells express TCRb on the cell surface (Fig. 8C, shown for DA vs.
DA.1UR83).
Positive selection takes place in the thymic cortex where DP
cells expressing intermediate levels of TCR interact with MHC
expressing stromal cells. DP cells that express a functional TCRa
chain, which can pair with TCRb and recognize self-MHC, are
positively selected. We determined the total number of DP cells in
the thymus and found lower numbers in the strains expressing
RT1-Aa and TAP-B (DA.1HR10, DA.1UR10) (Fig. 8D). In
addition, DP cells in these strains showed a greater proportion of
mature cells, which express high levels of TCR and CD5 (Fig. 8D)
[64]. Such a reduction of DP cells was not observed in other
strains with low expression of class I, such as DA.1IR85 (RT1-An,
TAP-A) (data not shown), suggesting that it is not the lower
expression of class I that influences the number of DP cells in
DA.1HR10 and DA.1UR10 but rather the quality of the class-I
peptide repertoire.
Next, we determined how genes in the MHC-I and II regions
influence lineage commitment and negative selection. TCR cross-
linking of DP cells in vitro has been shown to generate CD8SP cells
in the rat and CD4SP cells in the mouse [66,67]. As shown in
Figure 8E, ,60% of CD8SP cells in DA express low or
intermediate levels of TCR, which is in marked contrast to
CD8SP cells in the mouse where essentially all are TCRhi [68].
However, both the frequency and the total number of CD8SP
TCRhi cells varied substantially among the strains: the majority of
CD8SP cells in strains with TAP-A expressed low TCR levels
whereas most CD8SP cells in DA.1HR10 and DA.1UR10 (TAP-
B) were TCRhi (Fig. 8E and 8F). A similar increase in TCRhi
expressing CD8SP cells was not observed in DA.1H (RT1-Ah,
TAP-B) (Fig. 8F), indicating that the increase of CD8SP cells in
DA.1HR10 (RT1-Aa, TAP-B) is cim-dependent. Neither was it
observed in Tcs1-congenic strains with low surface expression of
class I (DA.1HR83, DA.1IR85; Fig. 8F), which suggests that it is
the quality of the peptide repertoire and not the lower expression
of class I that is responsible for the increase of CD8SP TCRhi cells
in DA.1HR10 and DA.1UR10.
In contrast to CD8SP cells, virtually all CD4SP cells were
TCRhi (Fig. 8G). All Tcs1-congenic strains had similar numbers of
CD4SP cells (data not shown), while we observed an increase of
total CD4SP cells in DA.1HR10 and a decrease in the same subset
in DA.1FR9 compared to DA and DA.1UR10 (Fig. 8G). The
variation in the number of CD4SP cells probably reflects the
genetic variation in the classical MHC class II genes, in particular
in the RT1-B genes since the RT1-D genes are conserved between
DA and DA.1FR9 (Fig. 4). It is further unlikely that the variation
in CD4SP cells is cim-dependent since only DA.1HR10, and not
DA.1UR10, showed an increase in CD4SP cells.
These data suggest that classical cim reduces negative selection
of class I restricted thymocytes, probably by limiting the
Figure 7. Tcs1 and Tcs2-congenic strains show similar variation
in extracellular MHC expression in thymus and spleen. (A)
Thymic conventional DCs (CD103+, CD11b/c+) stained extracellularly for
class I (OX18). Scatterplots show results from two different experiments
with Tcs1 and Tcs2-congenic strains. The variation between the strains is
comparable to data shown in Figure 5 for CD68+ cells. (B–C) Splenic
DCs (CD103+, CD68+, CD11b/c+) (B) and thymic DCs (C) stained
extracellularly for RT1-D (OX17) and RT1-B (OX6). Histograms show
representative samples from DA (solid lines) and DA.1HR10 (dashed
lines).
doi:10.1371/journal.pgen.1004151.g007
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complexity of available peptides in the ER. In addition, cim may
influence positive selection as shown by the reduced number of DP
cells in DA.1HR10 and DA.1UR10.
Classical cim influences the number of peripheral CD8 T
cells
Class-I modification was associated with an increased number of
CD8SP TCRhi cells in the thymus. However, it was unclear whether
this also led to an increase of CD8 T cells in the periphery. Thus, we
assessed the number of CD8 recent thymic emigrants (RTEs), which
in the rat can be distinguished by their expression of CD90 (Thy-1)
and CD45RC [69,70], in the spleen of 6.5 week-old Tcs2-congenic
rats. The total number of CD8 RTEs was found to be significantly
increased in DA.1HR10 and DA.1UR10 (RT1-Aa, TAP-B)
compared to DA and DA.1FR9 (RT1-Aa, TAP-A). Furthermore,
the number of CD8 RTEs in the spleen correlated significantly with
the number of CD8SP TCRhi cells in the thymus (R2 = 0.83; P,
0.001), indicating that CD8SP TCRhi cells constitute a mature
subset of thymocytes. CD8SP cells with low or intermediate TCR
expression, by contrast, showed a weak inverse correlation with
CD8 RTEs in the spleen (data not shown). Similarly to the CD8
RTEs, the CD4 RTEs in the spleen strongly correlated with CD4SP
cells in the thymus (Fig. 9B). Differences in CD4 and CD8 RTEs
were less pronounced in older rats (13–14 weeks of age), which also
showed less, and slightly different, variations in total CD4 and CD8
T cell numbers compared to younger rats (Fig. S11). This
emphasizes that other mechanisms, such as clonal expansion, may
be more important than thymic output for maintaining the
proportions of CD4 and CD8 T cells in older rats.
We further compared CD8 T cell numbers between heterozy-
gous and homozygous DA.1HR61 (Fig. 2) and DA.1UR10 rats
(both Tap2B). Since the Tap2B allele is recessive [29], it was
Figure 8. Class-I modification reduces negative selection of CD8 cells. (A) The QTLs in Tcs1 and Tcs2 did not affect the total number of
double negative cells (DN; CD42, CD8b2). B cells (CD45RA+) were excluded from the DN gate. (B) DN cell maturation is defined by CD45RC and CD2
(see Fig. S10). DN cells in DA.1FR9 showed a lower frequency of early thymic precursors (ETP) compared to DA. Counter plot shows gating strategy
with numbers indicating percent (%) of parent population (stated above plot). (C) Counter plot shows CD45RC2, CD2hi DN cells from DA.1UR83, and
scatter plots the frequency of TCRb2 and TCRb+ (DN4 in mouse) cells in DA and DA.1UR83. (D) Thymi from Tcs2-congenic strains with TAP-B (HR10
and UR10) contained fewer double positive (DP) cells but more cells (in %) with high TCR expression. (E) TAP-B strains (HR10 and UR10) showed
higher frequencies (histograms) and total numbers (scatter plots) of CD8 single positive (SP) cells with high TCR expression. Numbers (%) in
histograms represent mean-values6SD of cells with high TCR expression (gated, n= 5). (F) Frequencies (histograms; n=5) and total numbers (scatter
plot) of CD8SP cells with high TCR expression in DA.1H (RT1-Ah, TAP-B) and in strains with low levels of surface MHC class I (HR83 [RT1-Ah, TAP-A] and
IR85 [RT1-An, TAP-A]). (G) Virtually all CD4SP cells express high levels of TCR. Histogram shows expression of TCR on CD4SP thymocytes in DA (n= 5).
Scatterplot shows total number of CD4SP cells per thymus in Tcs2-congenic strains.
doi:10.1371/journal.pgen.1004151.g008
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expected that rats with heterozygous Tap2 alleles had fewer CD8
T cells in the spleen compared to their Tap2B homozygous
littermates (Fig. 9C). However, they had also fewer CD8 T cells
than their DA littermates, a phenomenon known as under-
dominance, which has not previously been reported for T cell
selection. The impact of heterozygosity was the opposite in
DA.1UR83 (Tap2A), in which heterozygous rats had more CD8 T
cells than their homozygous littermates (so called overdominance)
(Fig. 9C). Hence, these phenomena were not directly related to
cim but seem to be specific for the CD8 lineage, and may reflect
the default CD8 lineage choice that has been reported in the rat
[66,67].
Taken together, we show that cim reduces negative selection of
CD8 cells, increases the thymic output of CD8 T cells and
thereby significantly contributes to the peripheral CD8 T cell
repertoire.
Discussion
We show that two linked haplotypes in the MHC-I and II
regions control MHC expression and T cell selection in rats. A
recombination between these haplotypes, which broke the
evolutionary conserved linkage between RT1-A and Tap2, affected
negative selection and lineage commitment of CD8 cells. This
effect was found to be associated with the Tap2B allele and
dependent on the co-expression of RT1-Aa. The same combination
of alleles has previously been shown to reduce the expression and
alter the antigenicity of the RT1-Aa molecule, a phenomenon
known as class-I modification (cim) [61]. We found in addition
that the combination RT1-Ah and Tap2A, encoding for the
promiscuous TAP-A transporter, also reduced the extracellular
expression of class I, which we term inverse cim. Thus, our results
show how natural polymorphisms in Tap2 modify class I
expression and alter T cell selection in rats.
Following the identification of Tap2 as a trans-acting modifier of
RT1-Aa antigenicity [25], it has been thoroughly investigated how
different TAP transporters are associated with changes in RT1-A
protein expression and the RT1-A peptide repertoire. These
studies suggest that TAP-A and TAP-B are equally efficient in
transporting peptides with hydrophobic C-terminal residues, while
TAP-B has weak affinity for peptides with basic C-terminal
residues [18,22,26–28]. These differences were exploited here to
assess how an altered spectrum of class I peptides influences T cell
Figure 9. Classical cim influences the number of CD8 recent thymic emigrants. (A) Recent thymic emigrants (RTEs) express CD90 and low
levels of CD45RC. Counterplots show CD8 RTEs (gated) in the spleen of 6.5-week old congenic and DA rats (representative samples, numbers in gates
show percent of CD8 T cells). Scatterplot shows total number of CD8 RTEs per spleen, which correlates to the absolute number of CD8SP TCRhi cells in
the thymi from the same animals (far right). (B) The corresponding staining (as shown in A) for CD4 RTEs, including total numbers (scatterplot) and
correlation to CD4SP TCRhi cells in the thymus. (C) Absolute numbers of CD4 (blue) and CD8 (red) T cells in the spleen of 13-week old rats. Strains and
genotypes are shown above and below graphs, respectively; n=5–7 per group.
doi:10.1371/journal.pgen.1004151.g009
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selection in animals with natural variations in the TCR and MHC
loci.
Thymic DCs in the corticomedullary junction present antigens
to positively selected thymocytes ([71], reviewed in [72]).
Thymocytes with high affinity for self-peptide:MHC complexes
are eliminated through negative selection. However, if the peptide
repertoire on the DCs is limited, as in DA.1HR10 and DA.1UR10
(RT1-Aa, TAP-B), fewer thymocytes will express TCRs with high
affinity for peptide:MHC complexes and fewer cells will therefore
undergo negative selection. We showed in addition that less
negative selection in rats with RT1-Aa and TAP-B allotypes
correlated with an increased number of CD8 RTEs in the
periphery. Thus, it seems possible that cim may lead to an escape
of autoreactive CD8 T cells. Preliminary results from our
laboratory, however, show that CD8 cells from DA.1HR10 and
DA.1UR10 produce lower levels of pro-inflammatory cytokines
compared to strains expressing RT1-Aa and TAP-A (Tuncel and
Haag, unpublished data).
Although the major effect of cim appears to be during negative
selection, it also influenced the number of DP cells. This finding is
consistent with studies in fetal thymus organ cultures in which a
complex mixture of class-I peptides has been shown to increase
positive selection [68,73]. Hence, it seems reasonable that fewer
thymocytes will be positively selected in strains, such as
DA.1HR10 and DA.1UR10, where the class I peptide repertoire
is limited by the restrictive TAP-B transporter. In contrast to
negative selection, positive selection is largely dependent on
cortical thymic epithelial cells (cTECs). Interestingly, in the mouse
it has been shown that thymic DCs express 106 higher levels of
MHC class I than cTECs [74]. This latter subset is still poorly
characterized in the rat and we have therefore not been able to
determine the expression of class I on these cells. However, it
seems likely that different allelic variants of Tap2 would also affect
the expression of class I on epithelial cells. The increased number
of DP thymocytes should therefore be further investigated
considering the lower expression of MHC class I described on
cTECs in the mouse and the fact that the processing of antigens in
these cells is different due to a thymoproteasome specific subunit
encoded by PSMB11 [75,76].
Cim did not affect TCR selection at the early DN stage. All
strains, regardless of Tap2 genotype, had similar number of DN
cells and normal transition from early thymic precursors to more
mature TCRb+ cells (DN4). By contrast, the frequency of early
thymic progenitor cells was reduced in DA.1FR9, which is
congenic for the Tcs2 interval as well as the entire MHC-III region
and parts of the non-classical MHC class Ib (RT1-CEM) region. A
potential candidate in the MHC-III region, which could influence
the regulation of DN cells in this strain, is Notch4. Notch4 is
expressed in the thymus [77] and has been shown to influence
lymphoid progenitor fate [78] while another Notch family
member, Notch1, has been shown to determine early commitment
to T cell lineage [79]. We have recently obtained a new RCS,
DA.1FR61 (Fig. 2), which excludes Notch4 and future studies on
this strain will help delineate whether Notch-4 is involved in the
regulation of DN cells.
We did not find evidence for a correlation between class I
expression levels and T cell selection. All Tcs1-congenic strains
showed low levels of extracellular class I expression (compared to
DA) but varied widely in their CD8 cell numbers. Damoiseaux et
al. suggested that the expression of two RT1-A genes in the BN
strain, compared to one in LEW, was responsible for the increased
negative selection of CD8 cells in the LEW.1N strain [36]. This
reduction of CD8 cells is probably associated with the RT1-A
locus (RT1-An) in LEW.1N and thus the same phenotype as we
mapped in DA.1IR85. We determined the expression of the two
RT1-A genes (A1n and A2n) in DA.1IR85 and although both genes
were highly expressed, the level of class I protein at the cell surface
was low compared to DA. However, the low surface level of class I
in DA.1IR85 is probably dependent on the presence of TAP-A in
this strain, while RT1-An in LEW.1N is associated with TAP-B.
Thus, it is unlikely that the reduction of CD8 cells in DA.1IR85
and LEW.1N [36] is associated with the levels of class I expression
on the cell surface. However, that CD8 selection would be
influenced by the number of protein-coding class I genes, as
proposed by Damoiseaux et al. [36], remains an attractive
hypothesis. It is further interesting to note that also DA.1HR83
expresses two RT1-A genes and has low numbers of CD8 cells,
while DA and DA.1UR83, which have higher numbers of CD8
cells, only express a single RT1-A gene each. However, whether it
is the number of expressed class I genes or the increased diversity
of class I peptides that promote clonal deletion of CD8 cells
remains to be tested in more strains.
We further noted that QTLs for the expression of class I (Q2 on
RNO2, Q6 on RNO10) and class II (Q1 on RNO2, Q7 on
RNO17) did not co-localize with QTLs for the CD4:CD8 T cell
ratio in the HS rats. Thus, Tap2 remains, at least to our knowledge,
the only naturally selected non-classical MHC gene that has been
found to be associated with both variations in MHC surface
expression and CD4:CD8 lineage commitment. In addition to the
MHC, a second major QTL controlling CD4:CD8 T cell variation
was identified within a narrow region on chromosome 9. A gene at
this locus, Satb1, is predominantly expressed in the thymus [80].
Reduced expression of Satb1 at the protein level has been shown to
be associated with a reduction in the frequency of CD8SP cells in
the thymus as well as in the periphery [81]. Variation in CD8 T cells
in the HS rats, however, did not correlate with the allelic
distribution of Satb1, nor did the gene expression of Satb1 in the
thymus of 136 HS rats (data not shown).
A strong correlation similar to that we showed for Tap2 and
CD8 selection could not be found for any gene in Tcs2 and CD4
selection. Apart from the extensive diversity we observed in RT1-
Db1, Ba and Bb, several non-synonymous SNPs were in addition
identified in RT1-DOb. This gene encodes one subunit of the non-
classical class II molecule DO. The human homologue, HLA-DO,
which has been shown to be expressed in the thymus [82],
competes with the peptide editor HLA-DM for the binding of
MHC class II molecules [83,84]. Hence, polymorphisms that alter
the affinity of DO for MHC class II may also affect the peptide
repertoire of the MHC class II molecule and, thus, the selection of
T cells. We found in addition evidence on transcript and protein
level for a second RT1-Db locus (Db2), which is probably the rat
ortholog of murine Eb2 [85]. Similar to the mouse gene, Db2
appears to be highly conserved among inbred rat strains. The
genetic interaction between allotypes of TAP and RT1-A for the
selection of CD8 T cells raises the question whether a similar
interaction exists between the two highly polymorphic class II
molecules (RT1-B and RT1-D) and alleles of RT1-DOb for the
selection of CD4 T cells. Such interaction could be one
explanation for the strong LD between these genes.
It has been a long-standing question why the rat has two TAP
variants [24], in particular since the restrictive TAP-B transporter
does not seem to offer advantages over the promiscuous TAP-A
transporter. The redundancy of the TAP-B transporter has also
been shown experimentally in the PVG.R23 recombinant strain in
which RT1-Au, which is typically found associated with TAP-B, is
expressed together with TAP-A [61]. In this strain, the association
with TAP-A did not influence the expression of class I, which is
consistent with our results in DA.1UR83. It was therefore
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somewhat surprising that certain other RT1-A allotypes appear to
be dependent on the association with TAP-B for optimal
expression on the cell surface. We termed this phenomenon inverse
cim and showed that the extracellular expression of RT1-Ah is
reduced when the molecule is associated with TAP-A compared to
TAP-B. The same seems to be true for the RT1-An molecule(s) in
DA.1IR85, although the linkage to TAP-A in the parental strain
made it difficult to further address this question. One of the
antibodies, F16-4-4, used to determine the inverse cim for the
RT1-A molecules in DA.1HR83 has been shown to bind the A1h
but not the A2h isoform (Anne France Le Rolle, personal
communication). Thus, the inverse cim reduces the expression of
A1h while it remains to be investigated whether it also reduces the
expression of A2h.
The expression of RT1-A at the gene level did not correlate well
with the protein expression on the cell surface and did not explain
the low levels of extracellular class I in DA.1HR83 and DA.1IR85.
In DA.1HR83, the expression of A2 was ,15-fold higher
compared to A1, which is inconsistent with the idea that if any
allele is expressed at the A1 locus, this allele will function as the
principle class Ia molecule [18]. However, since both isoforms
were detected at the protein level, it remains possible that A1
indeed is the dominant class Ia molecule in DA.1HR83, despite
being expressed at a lower level. By contrast, RT1-A1n showed a 5-
fold increased expression over RT1-A2n in DA.1IR85, and both
isoforms were readily detected at the protein level. There was no
evidence at the protein level for an A3 isoform, which may suggest
that DA.1IR85 has not acquired all functional class Ia genes from
BN. The class Ia molecules in DA.1IR85 further differed from
DA.1HR83 by a high intracellular expression in lymphocytes,
while a similar difference was not observed for myeloid cells. It
should be noted that the OX18 antibody used for the intracellular
staining of MHC class I also recognizes MHC class I in the
absence of b2-microglobulin. Hence, the high intracellular levels
of MHC class I in DA.1IR85 lymphocytes do not necessarily need
to reflect an increase in mature peptide-loaded molecules. An
interesting possibility is that the differences in intracellular class I
levels between leukocyte lineages is regulated at the transcript
level, which could suggest that the expression of A1 and A2 in
DA.1IR85 is lineage specific. This has indeed been shown
previously in rhesus macaques where specific class Ia transcripts
have been associated with either myeloid or lymphoid lineages
[86].
Co-evolution of genes in the class I and Tap loci is certainly not
an isolated phenomenon in the rat, although the class I genes are
separated from the TAP genes by the class II region in the
majority of mammals. The class I molecules in both humans and
mice have evolved to accommodate peptides that are supported by
their associated TAP transporters, while the Tap1 and Tap2 genes
themselves have remained functionally monomorphic. By contrast,
functional alleles of Tap2 that have co-evolved specifically with
different alleles of class I have been described in the chicken [87].
The Tap genes in the chicken are directly flanked by class I genes
[88], which probably have preserved the linkage. In the rat, by
contrast, the Tap2 and class I loci are separated by a ,250 kb
interval, which is relatively susceptible to recombinations (Fig. 3).
On the contrary, the recombination activity between Tap2 and the
class II genes is extremely low as shown in this study. This may
suggest that alleles of Tap2 have been conserved in the rat in cis-
configuration with alleles in the RT1-B and RT1-D loci. This
linkage may not have been maintained in species that lack
functional polymorphisms in the Tap genes, such as in the mouse
[89–91] and in humans [92]. Highly conserved MHC-II
haplotypes are also evident in many inbred and partially outbred
rat strains [13], with the only exception to our knowledge being
the WRC strain that has a recombination in the RT1-B locus [93].
In addition, several related inbred strains, which have been
derived from outbred stocks, have recombinations between Tap2
and RT1-A, e.g. LN (Tap2B) vs. LL (Tap2A), and FHL (Tap2B) vs.
FHH (Tap2A) [13]. With an increasing number of genome
sequences available, and the possibility to obtain sequence
information from wild rats, it might be possible to investigate
whether the strong linkage between Tap2 and the class II genes is
associated with certain haplotypes and bears an evolutionary
advantage.
In summary, we mapped two QTLs associated with variations
in CD4:CD8 lineage commitment and MHC expression to the
MHC-I and MHC-II region in the rat. A recombination between
these two regions modifies class I expression by breaking the
linkage between co-evolved RT1-A and Tap2 alleles, which
previously has been described as class-I modification (cim). We
demonstrate a novel type of cim and also show that certain
combinations of RT1-A and Tap2 alleles are not affected by cim.
Furthermore, we show that cim had a pronounced effect on
thymic selection. Cim did not influence DN stages, but decreased
the number of DP thymocytes. Most importantly, cim rescued
CD8 T cells from negative selection and thereby increased the
number of CD8 T cell in the periphery.
Materials and Methods
Ethics statement
All experiments involving animals were approved by the local
ethics committees at Karolinska Institutet, Stockholm, or by the
Spanish legislation on ‘‘Protection of Animals Used for Experi-
mental and Other Scientific Purposes’’ and the European
Communities Council Directive (86/609/EEC) on this subject.
Animals
NIH-HS. The origin of the strains and the outbreeding
regime that was used to create and maintain the NIH-HS have
been described elsewhere [42]. Briefly, the colony was founded
from 8 inbred progenitor strains: BN/SsN (RT1n), MR/N (RT1d),
BUF/N (RT1b), M520/N (RT1b), WN/N (RT1l), ACI/N (RT1a),
WKY/N (RT1l), and F344/N (RT1lv1) [37]. Animals were housed
in open polycarbonate (Makrolon) cages at a temperature of
22uC62uC and with 12 h light-dark cycle and fed standard rodent
chow and tap water ad libitum.
Congenic strains. Inbred DA/Ztm rats were obtained from
the Zentralinstitut fu¨r Versuchstierzucht (Hannover, Germany)
and DA/OlaHsd from Harlan Europe (Horst, the Netherlands).
Rats were maintained in a barrier facility by sister-brother mating
and were specific pathogen free according to the current FELASA
guidelines. Animals were kept in a climate-controlled environment
with 14 h light/10 h dark cycles, in individually ventilated
microisolator-cages (Allentown Inc. NJ, USA) containing wood
shavings and fed standard rodent chow and microfiltered water ad
libitum. Congenic strains were originally established on DA/Ztm
background (N.20) and thereafter further backcrossed (N.5) to
DA/OlaHsd. The RCS were produced by crossing F1 hybrid rats.
The derivation of DA.1FR9, DA.1FR10, DA.1FR8 and DA.1FR5
from congenic DA.1F (DA.LEW-RT1f) has been described
previously [94]. RCS with MHC haplotype RT1u were derived
from DA.1U, which was generated by introgression of the
corresponding E3/ZtmRhd fragment on chromosome 20. RCS
with MHC haplotypes RT1i and RT1h were derived from DA.1I
and DA.1H, respectively (both established at the Zentralinstitut fur
Versuchstierzucht). The RT1i haplotype originates from the now
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extinct BI (formerly called B3) strain [95] and the RT1h haplotype
from the KHW strain. DA.1I contains a derivative MHC
haplotype (RT1-AiBaDa); however, several STRs and SNPs in
the MHC-II region and, to a lesser extent, in the MHC-III and Ib
regions are polymorphic between DA.1I and DA. RT1h is a
standard haplotype [56] but most genetic variants in the MHC-II
region are shared with RT1n (this study). Several genes in the
MHC-Ia region (including RT1-A1 and RT1-A2 [sequences from
GenBank]) and the MHC-III region, however, are unique for
RT1h (Tuncel and Yau, unpublished data). Additional information
about strains can be found on our website http://www.inflam.
mbb.ki.se/rat/MHC. The QTLs described have identification
numbers 7175096 (Tcs1) and 7175099 (Tcs2) in the Rat Genome
Database (RGD) (http://rgd.mcw.edu/rgdweb/search/qtls.html).
Genotyping
NIH-HS. Information on polymorphic SNPs was provided
through the STAR consortium that identified SNPs and haplo-
types in the rat to assist complex trait analysis as part of the
EURATRANS consortium. DNA was extracted from liver
biopsies using a standard proteinase K protocol. Genotyping was
performed using a custom-designed high density Affymetrix SNP
genotyping array (RATDIV), which is based on sequence
information from 13 inbred rat strains. The array interrogates
803,485 SNPs of which 265,551 polymorphic high quality SNPs
were chosen for the reconstruction of the HS chromosomes as a
mosaic of the founder haplotypes as described below.
Congenic strains. Genomic DNA was extracted from
biopsies as has been described previously [94]. PCR primers for
short tandem repeats (STRs) and SNPs were retrieved from the rat
genome sequence 3.4/rn4 2004 assembly and designed using
PrimerSelect 8.1.3 (Lasergene, DNAstar Inc., WI, USA). Forward
primers were fluorescently labelled with 6-FAM, HEX, VIC, PET
or NED (MWG Biotech, Riskov, Denmark). STRs were amplified
with PCR according to standard protocols, diluted in HPLC
water, combined with the size standard Liz-600 in 10 ml HiDi
formamide (both from Applied Biosystems, CA, USA) and
analyzed on a 48-capillary 3730 DNA analyzer (Applied
Biosystems). SNPs were genotyped by Sanger sequencing as
described below.
Exon sequencing
RNA was extracted from spleen using the RNeasy Mini kit
(Qiagen, Ballerup, Denmark) and treated with DNase I (Roche,
Mannhein, Germany). Complementary DNA (cDNA) was syn-
thesized with iScript (Bio-Rad, CA, USA). Genomic DNA (gDNA)
was isolated from spleen by proteinase K digestion (AquaPure
Genomic DNA kit, Bio-Rad). Primer sequences were obtained
from the RefSeq 3.4 genome assembly. All sequences were
obtained through conventional capillary sequencing except Btnl2,
which was sequenced on the SOLiD platform (Applied Biosys-
tems). For capillary sequencing, products were amplified in a 25 ml
PCR reaction containing 0.5 mg DNA, 2 ml 2.5 mM dNTP (New
England Biolabs), 1 ml 50 mM MgCl2, 0.1 ml Platinum Taq
(Invitrogen, CA, USA) and 0.5 ml of each 10 mM primer. The
products were purified using the Millipore’s Montage Cleanup Kit
and diluted in HPLC water or were isolated by agarose digestion
after gel electrophoresis. Sequencing was performed with BigDye
Terminator v3.1 according to instructions (Applied Biosystems)
using 0.4 mM of single primers. Products were purified by ethanol
precipitation, resuspended in 10 ml HiDi formamide and analyzed
on a 48-capillary 3730 DNA analyzer. Nucleotide sequences have
been submitted to GenBank (http://www.ncbi.nlm.nih.gov/
genbank) under accession numbers KC222882–KC222951.
Flow cytometry
Analysis of PBMCs from NIH-HS rats has been described
recently [41]. Briefly, phenotyping were performed in 8 cohorts of
230–270 individuals over 3 years. Rats had been subjected to
behavioral tests (week 8–10) prior to blood sampling (week 13), but
besides from a wound-healing test (puncture of the external ear) in
week 7 and a glucose tolerance test (week 11), no invasive
procedures had been performed. Twenty ml blood was stained for
20 min in duplicates with saturating concentrations of fluores-
cently-labeled monoclonal antibodies (MAbs, see below). After
erythrolysis, cells were fixed for 20 min at RT in a 2% phosphate-
buffered formaldehyde solution and then washed twice in PBS
before acquisition.
Congenic strains. For analysis of MHC expression on DCs,
tissues were cut into ,1 mm3 cubes and incubated with 2 ml
digestion buffer containing 2.5 mg/ml collagenase IV (Sigma-
Aldrich, MO, USA), 0.2 mg/ml bovine pancreas DNase I (Roche
Applied Science), 2% fetal calf serum (FCS, Gibco Laboratories,
MA, USA) in Hank’s Balanced Salt Solution (HBSS) (Sigma-
Aldrich) for 20 min at 37uC. Undigested material was disrupted by
pipetting, 2 ml fresh digestion buffer was added and the
incubation was continued for 10–15 min. The digestion was
stopped by adding EDTA (Merck) to a finale concentration of
20 mM. After incubation for 5 min in EDTA on an orbital shaker
(100 rpm) at RT, the suspensions were filtered through 40 mm cell
strainers (BD Falcon), and washed twice in ice-cold FACS buffer
(calcium- and magnesium-free PBS-D supplemented with 1%
FCS, 10 mM EDTA and 0.02% NaN3). For thymocyte and
lymphocyte analyses, single-cell suspensions were prepared with-
out collagenase/DNase I treatment, filtered through 40 mm cell
strainers, washed twice in cold EDTA-FACS buffer and
resuspended in the same buffer and counted on a Sysmex KX-
21N. 106 cells/well were added in duplicates to 96-well v-bottom
polypropylene plates (BD Falcon) and stained with saturating
concentrations of MAbs (30 ml finale staining volume). The
following Alexa Fluor 488, FITC, PE, Pe-Cy5, PerCP-Cy5.5,
APC, APC-Cy7, Pe-Cy7, Alexa Fluor 648 and biotin conjugated
antibodies were used: CD4 (OX35), CD8a (OX8), CD8b (341),
CD45RA (OX22), anti-granulcoytes (His48), RT1-B (OX6), RT1-
D (OX17), MHC class I (OX18) were purchased from BD
Pharmingen (CA, USA); CD45 (OX1), CD45RA (OX33), CD90
(OX7), CD4 (W3/25), CD11b/c (OX42), CD103 (OX62) and ab-
TCR (R73) were purchased from BioLegend (CA, USA); CD68
(ED1) and RT1-A (F16-4-4, conjugated in-house with Alexa Fluor
647 using the APEX labeling kit, Invitrogen) were obtained from
AbD Serotec (Du¨sseldorf, Germany). CD2 (OX34) and CD5
(OX19) were produced in-house. To stain for b2-microglobulin
(using clone TLD-3H12B, BD), as an alternative to OX18, was
evaluated but did not result in reproducible data. R73 (ab-TCR)
was used to gate TCRb+ cells in the DN population (Fig. 8).
LIVE/Dead Violet (Invitrogen) was included in all stains to
exclude necrotic cells. For the intracellular staining of class I,
unlabeled OX18 or F16-4-4 was used to block extracellular
epitopes and the cells were thereafter incubated in BD Cytofix/
Cytoperm for 20 min at RT. Cells were then washed twice in BD
PermWash and stained intracellularly with labelled OX18 and
F16-4-4. A SORP BD LSRII Analytic Flow Cytometer or a
FACSCalibur (BD) were used for acquisition and the data was
analyzed with FlowJo (Tree Star Inc., OR, USA). Significant
differences between groups were analyzed using a non-parametric
test (Mann-Whitney U).
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Quantitative RT-PCR
RNA was extracted from 26106 non-stimulated spleen cells
using the RNeasy Mini kit (Qiagen) and treated with DNase I
(Roche). RNA concentration was determined spectrophotometri-
cally on a NanoDrop ND-1000 (NanoDrop Technologies, DE,
USA), diluted to 60 ng/ml and reverse transcribed to cDNA using
High Capacity cDNA Reverse Transcription (Applied Biosystems).
Quantitative real-time PCR (qPCR) was performed on an ABI
7900HT (Applied Biosystems) using SYBR Green (Applied
Biosystems) and a two-step PCR protocol (95uC for 10 min
followed by 40 cycles of 95uC for 10 sec and 60uC for 30 sec).
Allele-specific primers (Table S3) for RT1-Aa, RT1-Au, RT1-A1n,
RT1-A2n, RT1-A1h, RT1-A2h and clone 3.6 were designed using
NCBI/Primer-BLAST with sequences retrieved from public
databases. The performances of all primers were evaluated prior
to use to ensure that all PCR reactions were performed at
comparable efficiencies. In the final experiments, each target was
amplified using 2–4 different primer pairs and the cycle threshold
(Ct) values were then averaged at the gene level. Average Ct-values
were compared to beta-2-microglobuline or normalized to the
geometric mean of the reference genes Arbp, Hprt-1 and Mdh-1
(Table S3), whereafter fold-change variations were determined
using the relative quantification method (DDCt).
Microarray
Array hybridization. Thymi and inguinal lymph nodes
(iLN) were removed from DA.1IR83 rats and non-congenic
littermates (n = 6) immediately post mortem. To minimize the risk
of blood contamination in the thymi, the aorta was first incised
below the chest to allow blood to drain into the abdominal cavity.
Whole organs were excised, instantly frozen in liquid nitrogen and
stored at 270uC until prepared. RNA extraction and array
hybridization were performed as previously described [96]. Briefly,
total RNA was extracted using TRIzol reagent, and further
purified and DNase I treated using an RNeasy Mini kit (Qiagen)
and RNase-Free DNase Set (Qiagen), according to the manufac-
turer protocols. RNA quality was assessed using the Agilent 2100
Bioanalyzer (Agilent Technologies, CA, USA). A total of 1 mg
RNA was used for array hybridization against Affymetrix
GeneChip Rat Exon 1.0 ST Arrays in accordance with the
recommendations of the manufacturer (Affymetrix).
Data analysis. CEL intensity files were produced using
GeneChip Operating Software version 1.4 (Affymetrix) and
quality tested using the Affymetrix Expression Console. Detection
of differential expression was performed at the gene level using the
Partek Genomics Suite 6.4 (Partek Incorporated, MO, USA) and
summarized at the gene level using a One-Step Tukey’s Biweight
Algorithm.
Mass spectrometry
For the detection of class I derived peptides, single cell
suspensions were prepared from spleens in PBS after lysis of
erythrocytes. Cells were washed and taken up in 5% FCS
supplemented DMEM-medium. 30 million cells were incubated
for 7 hours at 37uC with 10 ng/ml IFN-c, cells were washed in PBS
and subsequently lysed in PBS containing 1.2% (w/v) CHAPS (GE
Healthcare Life Sciences) and protease inhibitors (Complete, Roche
Applied Science). RT1-D was immunoprecipitated from spleen cell-
lysate using the monoclonal antibody OX-17. Proteins were
reduced using 5 mM dithiothreitol (DTT) in 50 mM NH4CO3 for
10 min at 90uC and alkylated with 10 mM iodoacetamide (IAA)
for 30 min at room temperature in the dark. Protein was
precipitated overnight at 220uC in 95% acetone, precipitate was
collected by centrifugation and washed with 80% acetone, 10%
methanol, 0.2% acetic acid and incubated for 30 min at 220uC.
Protein was pelleted by centrifugation and dissolved in 20 ml
DMSO, diluted to 50 mM NH4CO3 and 30% DMSO with a final
trypsin:protein ratio of 1:20 for in-solution digestion overnight at
37uC. Prior to MS analysis, the peptide mixture was dried,
reconstituted in 5% formic acid, and cleaned using ZipTipC18
(Millipore) [97]. LC-MS/MS analyses were performed on an Easy-
nLC system (Thermo Scientific, Bremen, Germany) directly on-
line coupled to a hybrid QExcative Orbitrap mass spectrometer
(Thermo Scientific). 1 mg of each sample was injected from a
cooled auto sampler onto the LC column, peptide separation was
performed on a 10 cm long fused silica tip column (SilicaTips, New
Objective Inc., MA, USA) packed in-house with 3 mm C18-AQ
ReproSil-Pur (Dr. Maisch GmbH, Ammerbuch, Germany). The
chromatographic separation was performed using an acetonitrile
(ACN)/water solvent system containing 0.2% formic acid with the
following gradient set up: 5–35% ACN in 90 min, 35–95% ACN
in 5 min and 95% ACN for 5 min all at a flow rate of 0.3 ml/min.
The MS acquisition method consisted of one survey scan ranging
from m/z 300 to m/z 1650 acquired in the FT-Orbitrap with a
resolution of R = 70,000 at m/z 200, followed by ten consecutive
data-dependent MS/MS scans from the top ten precursor ions with
a charge state $2. The MS/MS scans were fragmented using
HCD and acquired with a resolution of 17,500 at m/z 200. The
instrument was calibrated externally according to the manufactur-
er’s instructions and all samples were acquired using internal lock
mass calibration on m/z 429.088735 and 445.120025. Mass lists
were extracted from the raw data using the in-house written
software Raw2MGF, and searched using the Mascot search engine
(Matrix Science Ltd., London, UK) against a database consisting of
the IPI rat database (v. 3.82), all accessions matching rat in the
SwissProt database (downloaded 2011.04.05), as well as a protein
FASTA file containing translated Sanger-sequenced regions of
congenic MHC-II haplotypes (Fig. 4). The following parameters
were used: tryptic digestion with maximum 2 miscleavages;
carbamidomethylation of cysteines as a fixed modification;
oxidation of methionine and glutamine to pyroglutamate conver-
sions at peptide N-termini as variable modifications; precursor and
fragment tolerance set to 10 ppm and 0.1 Da respectively.
QTL mapping and statistical analysis
Genetic analysis was performed using HAPPY (http://www.
well.ox.ac.uk/happy/) to calculate the probabilities of descent
from the eight HS founders as described previously in [98]. To
account for relatedness, the Efficient Mixed-Model Association
eXpedited (EMMAX) method was used [41]. The negative logP
threshold necessary to achieve a false discovery rate (FDR) of 10%
across all traits was estimated by simulation to ,4.2. To account
for the complex family structure in the HS, we alternatively used
Bagphenotype [99], where each QTL is scored by its Resample-
based Model Inclusion Probability (RMIP). Confidence intervals
were calculated by simulation of phenotypes, each arising from a
single QTL, in addition to a correlated genetic random effect and
uncorrelated errors. All the genome scans and annotated QTLs
are publicly available from the website http://mus.well.ox.ac.uk/
gscandb/rat.
Supporting Information
Figure S1 The rat expresses two transcripts of RT1-DOb. (A)
PCR amplification of cDNA from the 4 haplotypes tested with
primers specific for RT1-DOb revealed two distinct products when
separated by gel electrophoresis. (B) Analysis of the two products
(shown in A) by Sanger sequencing revealed two transcripts of
Polymorphisms in Tap2 Influence T Cell Selection
PLOS Genetics | www.plosgenetics.org 17 February 2014 | Volume 10 | Issue 2 | e1004151
RT1-DOb (isf_1 and isf_2). The shorter transcript (Transcript
Variant 2; GenBank accession number KC222928–KC222931)
displayed a 77 bp deletion in exon 3 (red shaded area). (C) Amino
acid sequence of RT1-DOb (haplotype RT1av1) with the 26-residue
deletion in the b2 domain highlighted in red. (D) Structural model
of rat RT1-DOb isoform 1 (haplotype RT1n, accession ID
Q6MGA2). The red area illustrates the deletion in isoform 2
(Val 121-Thr146). (E) The shorter isoform of mouse H2-Ob
(haplotype H2-g7, accession number Q3T9T7) lacks the cysteine,
which corresponds to Cys143 in the long isoform of RT1-DOb,
and can therefore not form a cysteine bridge with Cys173. See
Figure S2 for the alignment of human, rat and mouse sequences.
(EPS)
Figure S2 MHC class II antigen DO beta chain alignment of
human, mouse and rat. The 26 amino acid deletion identified on
transcript level in rat RT1-DOb (see Figure S1) is also found in
human HLA-DOB and mouse H2-Ob. All sequences aligned are
based on evidence at the transcription level except for the 6 tryptic
peptides (underscored), which were identified by MS in the
proteome of B cells (see Methods). The tryptic peptides account in
total for 32% coverage of the mature protein (isoform 1) but do not
prove the existence of a shorter isoform. Residues marked with an
asterisk (*) are shared in-between species. Transcript with
accession number E9PND4 is a fragment, lacking exon 4–6.
(EPS)
Figure S3 Immunoprecipitation (IP) with anti-RT1-D alpha
identifies RT1-Db2 specific peptides in cell lysate from
DA.1HR61 and DA. RT1-Db2 was immunoprecipitated from
DA (a) and DA.1HR61 (h) lymph node whole-cell lysate using the
anti-rat RT1-D alpha specific antibody OX17. Identified peptides
(pep1-6) that were identified in only one of the two lysates are
marked as (a) or (h) whereas peptides that were identified in lysates
from both strains are depicted as (a, h). Only peptides with Mascot
scores .20 are shown. Identified peptides specific for RT1-Db1
are not shown in the alignment.
(EPS)
Figure S4 MHC class I molecules expressed in DA. Unique
peptides identified in trypsin digested IFNc-stimulated DA
splenocytes matching MHC class I entries on UniProt. Peptide 9
is specific to RT1-Aa (HA12_RAT). Peptide 17 is specific to clone
3.6 (HA11_RAT) and the RT1-Cf entry O62936_RAT. Peptide
1–2, 4–8, and 10–12 match to HA12_RAT, but not to the non-
classical HA11_RAT entry, while peptide 14–16 discriminate
clone 3.6 from RT1-Aa. Peptide 3 and 13 are shared between
RT1-Aa and clone 3.6. Shaded amino acids indicate residues in
the F pocket, which discriminate TAP-A from TAB-B-linked
RT1-A molecules [24]. ‘‘Specific’’ indicates that the peptide
matches only to the indicated entries on UniProt (other peptides
also match to other class I entries, e.g. from other haplotypes).
(EPS)
Figure S5 MHC class I molecules expressed in DA.1UR83.
Unique peptides identified in trypsin digested IFNc-stimulated
DA.1UR83 splenocytes matching MHC class I entries on UniProt.
Peptide 2 is specific to the UniProt entries Q31256_RAT,
Q95571_RAT, and Q95577_RAT, which all 3 refer to the gene
RT1-Au. Q95571_RAT is identical to Q31256_RAT, but lacks the
signal peptide. Q95577_RAT is identical to Q31256_RAT with the
exception of a Val to Ala substitution at position 313. Peptides 1 and
3–5 are shared between these RT1-Au entries as well as other rat
MHC class I molecules. Shaded amino acids indicate residues in the
F pocket, which discriminate TAP-A from TAB-B-linked RT1-A
molecules [24]. ‘‘Specific’’ indicates that the peptide matches only to
the indicated entries on UniProt (other peptides also match to other
class I entries, e.g. from other haplotypes).
(EPS)
Figure S6 MHC class I molecules expressed in DA.1IR85.
Unique peptides identified in trypsin digested IFNc-stimulated
DA.1IR85 splenocytes matching MHC class I entries on UniProt.
Peptide 9 and peptide 8 are specific to the following UniProt
entries Q6MGB9_RAT, E9PSS8_RAT, P79600_RAT,
P79588_RAT, which are different length variants of RT1-A1n.
Peptide 12 is specific to RT1-A2n and matches to the UniProt
entries P79602_RAT, E9PSX3_RAT, Q6MGB8_RAT, and
F7ERG5_RAT, which are different length variants of RT1-A2n.
Peptide 5, 10 and 11 further distinguish RT1-A1n from RT1-A2n,
but are also shared with other rat MHC class I entries. Peptide 1–
3, 4 and 6–7 are shared between RT1-A1n and RT1-A2n as well
as other rat MHC class I molecules. Shaded amino acids indicate
residues in the F pocket, which discriminate TAP-A from TAB-B-
linked RT1-A molecules [24]. ‘‘Specific’’ indicates that the peptide
matches only to the indicated entries on UniProt (other peptides
also match to other class I entries, e.g. from other haplotypes).
(EPS)
Figure S7 MHC class I molecules expressed in DA.1HR83.
Unique peptides identified in trypsin digested IFNc-stimulated
DA.1HR83 splenocytes matching MHC class I entries on UniProt.
Peptide 1 and peptide 7 are specific to RT1-A1h (Q9QYQ3_-
RAT). Peptide 11 is specific to RT1-A2h (Q9QYQ2_RAT) and
peptide 13 only matches to the UniProt entries O62936_RAT and
HA11_RAT. Peptide 4, 5, 8, 10 and peptide 12 further distinguish
RT1-A1h from RT1-A2h or clone 3.6, while peptide 3 and 6 are
shared between RT1-A1h, RT1-A2h and the two class Ib
molecules. Peptide 9 is shared between the two classical class I
molecules, but not with clone 3.6. Shaded amino acids indicate
residues in the F pocket, which discriminate TAP-A from TAB-B-
linked RT1-A molecules [24]. ‘‘Specific’’ indicates that the peptide
matches only to the indicated entries on UniProt (other peptides
also match to other class I entries, e.g. from other haplotypes).
(EPS)
Figure S8 F16-4-4 recognizes a polymorphic determinant on
MHC class Ia. The level of OX18 staining is ,30-fold higher
intracellularly than extracellularly, which probably reflects this
antibody’s affinity for MHC class Ib antigens. (A) DA splenocytes
were stained with different concentrations of fluorescent-labelled
anti-MHC class Ia and Ib (clone OX18) or anti-MHC class Ia
(F16-4-4) antibodies. For detection of intracellular MHC class I,
antibody epitopes on the cell surface were first blocked with
unlabeled antibody. Cells were then fixed, permeabilized and
stained intracellularly with fluorescent labelled antibodies using
the same volume as used for extracellular staining. Histograms
show samples with comparable mean fluorescent intensity when
stained with indicated antibody dilutions (in brackets) extracellu-
larly (red) and intracellularly (blue). (B) F16-4-4 binds a
paraformaldehyde (PFA) sensitive epitope on MHC class Ia
proteins. Non-permeabilized splenocytes from DA and DA.1IR85
were incubated with saturating concentrations of F16-4-4 (upper
panel) or OX18 (lower panel) before (+ PFA) or after (2 PFA)
incubation of cells in a 4% PFA solution. Note the decreased
F16-4-4 staining of PFA- treated cells from DA.1IR85, which
suggests that F16-4-4 binds a polymorphic determinant (similar
PFA sensitive epitopes were found in DA.1HR83 and DA.1UR83
(data not shown)). Gray histograms represent fluorescence minus
one (FMO) controls.
(EPS)
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Figure S9 Differentially expressed genes between DA and
DA.1IR83 are confined to the Tcs1 region. Microarray profile of
gene expression in thymus (blue) and inguinal lymph nodes
(purple) in DA.1IR83 and littermate DA rats (n = 6). Data show
gene expression fold change levels at FDR ,5% (above dashed
line) and ,10% (below dashed line). Asterisked genes are encoded
within the congenic segment. Up - and downregulated genes in
DA.1IR83 are shown on the right and left side of the vertical line,
respectively. For the expression levels of classical MHC class I
genes see Figure 6. Note that Cd8a and cathepsin W (Ctsw) are
predominantly expressed in CD8 T cells and that the fold-change
variation for these genes therefore is likely to reflect the variation
in total number of CD8 T cells between the strains.
(EPS)
Figure S10 Progression of rat thymocytes from double negative
to double positive stage. (A) Double negative (DN) cells in the rat
are CD44+, similar to DN1, DN2 and DN3 in the mouse, but
express no or very low levels of CD25 (IL-2 receptor; lower panel).
(B) Triple negative (TN; CD42, CD82, TCRb2) early thymic
progenitor cells express CD45RC and CD5 (upper left panel) and
low levels of CD2. CD2 expression increases when cells progress
into double negative stage (CD2hi, CD45RC+). A small number of
these cells stain positive with R73 (anti-abTCR), indicating that
they have started to rearrange and express TCRb (upper right
panel). More mature DN cells downregulate CD45RC to become
CD2hi, CD45RC2 (lower right quadrant). DN cells progress
through an immature CD8a single positive stage (ISP). These cells
have completed the rearrangement of the TCRb locus and express
low levels of TCRb on the cell surface. Cells in the final DN stage,
which correspond to DN4 in the mouse, express high levels of
TCRb on the cell surface. (C) Double negative cells progress into
double positive stage. CD25 expression increases with the
expression of TCRab on DP cells. Red arrows indicate the
progress of maturation and are based on [63,64].
(EPS)
Figure S11 Variation in CD4 T cell numbers decreases with
thymic output. (A) CD4 T cells in the spleen were stained for
CD90 and CD45RC (upper panel) or only for CD90 (lower panel)
in two different experiments to determine the frequency of recent
thymic emigrants (RTEs) in young (6 weeks of age) and old (13
weeks of age) DA and DA.1HR10 rats. The higher frequency of
RTEs in young DA.1HR10 rats compared to young DA rats is not
seen in the older rats and, hence, the variation in the total number
of CD4 T cells (shown in B), seen in young rats, disappears when
thymic output decreases in old rats.
(EPS)
Table S1 Polymorphic Short Tandem Repeat (STR) markers.
(DOC)
Table S2 Single Nucleotide Polymorphism (SNP) markers.
(DOC)
Table S3 Quantitative-RT-PCR primers.
(DOC)
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